Research
Energy balance
Most societies endorse GLP-1RA therapy in patients with established or high risk of CVD independently of glycaemia.
Clinicians should follow current guidelines endorsing GLP-1RA therapy for patients at high risk for CVD, regardless of their glycaemic control.
StrongSupportsmedium confidence
Subsequently, the place for GLP-1RA therapy has changed over recent years, with most societies endorsing GLP-1RA therapy in patients with established or high risk of CVD independently of glycaemia.
Why this rating
Based on consensus from multiple societies.
Source
Understanding the place for <scp>GLP‐1RA</scp> therapy: Translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selection
Christine R. Andreasen et al. · Diabetes Obesity and Metabolism · 2021
DOI 10.1111/dom.14500
reviewCited 36×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →